Provided by Tiger Trade Technology Pte. Ltd.

ADC Therapeutics SA

4.60
+0.36008.49%
Post-market: 4.720.1200+2.61%17:42 EST
Volume:1.30M
Turnover:5.83M
Market Cap:569.83M
PE:-3.19
High:4.62
Open:4.30
Low:4.23
Close:4.24
52wk High:4.80
52wk Low:1.05
Shares:123.88M
Float Shares:92.24M
Volume Ratio:2.41
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4417
EPS(LYR):-1.6246
ROE:-705.53%
ROA:-23.98%
PB:-2.39
PE(LYR):-2.83

Loading ...

ADC Therapeutics Announces LOTIS-7 Trial Update on ZYNLONTA Combination in Relapsed DLBCL

Reuters
·
1 hour ago

ADC Therapeutics to Provide Update on Lotis-7 Clinical Trial

THOMSON REUTERS
·
1 hour ago

ADC Therapeutics files to sell 14.7M common shares for holders

TIPRANKS
·
Nov 11

BRIEF-ADC Therapeutics SA - Selling Shareholders May Offer 14.7 Million Common Shares - SEC Filing

Reuters
·
Nov 11

ADC Therapeutics Sa - Selling Shareholders May Offer 14.7 Mln Common Shares - SEC Filing

THOMSON REUTERS
·
Nov 11

ADC Therapeutics FY2025 Q3 Earnings Call Summary and Q&A Highlights: Clinical Progress and Strategic Financial Moves

Earnings Call
·
Nov 10

ADC Therapeutics (ADCT) Earnings Call Transcript

Motley Fool Transcribing
·
Nov 10

ADC Therapeutics Q3 net income beats analyst expectations

Reuters
·
Nov 10

ADC Therapeutics SA reports third quarter 2025 net product revenues of $15.8 million

Reuters
·
Nov 10

BRIEF-ADC Therapeutics Q3 Income From Operations USD -30.969 Million Vs. IBES Estimate USD -34.6 Million

Reuters
·
Nov 10

ADC Therapeutics Sa: Incurred $0.4 Mln & $13.5 Mln in Restructuring, Impairment & Other Related Costs for Three & Nine Months Ended Sept 30

THOMSON REUTERS
·
Nov 10

ADC Therapeutics Q3 Adj Loss per Share $-0.19

THOMSON REUTERS
·
Nov 10

ADC Therapeutics Q3 Income From Operations USD -30.969 Million VS. Ibes Estimate USD -34.6 Million

THOMSON REUTERS
·
Nov 10

Press Release: ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update

Dow Jones
·
Nov 10

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 10

ADC Therapeutics SA expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
Nov 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 07

ADC Therapeutics SA expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
Nov 03

ADC Therapeutics SA to Release Third Quarter 2025 Financial Results

Reuters
·
Nov 03

ADC Therapeutics Sa : H.c. Wainwright Cuts Target Price to $7 From $8

THOMSON REUTERS
·
Oct 16